Endurant Capital Management’s Amphastar Pharmaceuticals AMPH Stock Holding History

Endurant Capital Management’s Portfolio AMPH Stock Details AMPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-48,825	Closed	-$787K	–	97
2016 Q2	$787K	Sell	48,825 -91,325	-65%	-$1.29M	0.26%	63
2016 Q1	$1.68M	Buy	140,150 +12,200	+10%	+$144K	0.54%	47
2015 Q4	$1.82M	Buy	127,950 +4,691	+4%	+$62K	0.61%	48
2015 Q3	$1.44M	Sell	123,259 -10,300	-8%	-$154K	0.48%	52
2015 Q2	$2.35M	Sell	133,559 -18,600	-12%	-$290K	0.69%	44
2015 Q1	$2.28M	Buy	152,159 +45,100	+42%	+$603K	0.75%	49
2014 Q4	$1.24M	Buy	+107,059	New	+$1.17M	0.49%	58

Other funds holding AMPH

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Teachers Advisors New York $81.7B AUM 13.62% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Endurant Capital Management's AMPH Position: Q3 2016 in Review

Endurant Capital Management sold out of Amphastar Pharmaceuticals (AMPH) in Q3 2016, closing a stake of 48,825 shares — an estimated $787K sold.

Endurant Capital Management first reported a position in AMPH in Q4 2014 and held it in 7 quarters. The position peaked at $2.35M in Q2 2015. 135 funds tracked by Wall St. Rank hold AMPH as of Q3 2016.

Endurant Capital Management reported no remaining Amphastar Pharmaceuticals position as of Q3 2016 after selling out during the quarter.
Endurant Capital Management sold 48,825 Amphastar Pharmaceuticals shares in Q3 2016, an estimated $787K.
Endurant Capital Management first reported a position in Amphastar Pharmaceuticals in Q4 2014 and held it in 7 quarters.
Endurant Capital Management's Amphastar Pharmaceuticals position peaked at $2.35M in Q2 2015.
135 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q3 2016.

Based on Endurant Capital Management's 13F filing for Q3 2016, filed 15 Nov 2016.